Structure-based design and analysis of MAO-B inhibitors for Parkinson's disease: Using in silico approaches

Molecular Diversity

Volumn 17, Issue 1, 2013, Pages 111-122

  Kare, Pavan ^a   Bhat, Jyotsna ^a   Sobhia, M Elizabeth ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

De novo ligand design; Docking; MAO B; Molecular dynamics; Parkinson's disease

Indexed keywords

MONOAMINE OXIDASE B INHIBITOR;

ARTICLE; COMPUTER MODEL; CRYSTAL STRUCTURE; DRUG DESIGN; MOLECULAR DOCKING; MOLECULAR DYNAMICS; NEUROPROTECTION; PARKINSON DISEASE; PREDICTION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

BRAIN; DRUG DESIGN; MOLECULAR DOCKING SIMULATION; MOLECULAR DYNAMICS SIMULATION; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE;

EID: 84873407204     PISSN: 13811991     EISSN: 1573501X     Source Type: Journal    
DOI: 10.1007/s11030-012-9420-z     Document Type: Article

References (29)

1. Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Investig 116:1744. doi: 10.1172/JCI29178
2. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909. doi: 10.1016/S0896-6273(03)00568-3
3. de Lau LML, Breteler M (2006) Epidemiology of Parkinson's disease. Lancet Neurol 5:525-535. doi: 10.1016/S1474-4422(06)70471-9
4. Bortolato M, Chen K, Shih JC (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60:1527-1533. doi: 10.1016/j.addr.2008.06.002
5. Arias-Carrion O, P ppel E (2007) Dopamine, learning, and reward-seeking behavior. Acta Neurobiol Exp 67:481-488
6. Factor SA (2008) Current status of symptomatic medical therapy in Parkinson's disease. Neurotherapeutics 5:164-180. doi: 10.1016/j.nurt.2007.12. 001
7. Braun GH, Jorge DM, Ramos HP, Alves RM, Da Silva VB, Giuliatti S, Sampaio SV, Taft CA, Silva CH (2008) Molecular dynamics, flexible docking, virtual screening, ADMET predictions, and molecular interaction field studies to design novel potential MAO-B inhibitors. J Biomol Struct Dyn 25:347-355
8. De Lano W (2002) PyMOL version 0.99. DeLano Scientific, San Carlos, CA
9. Sybyl T 7.0. Tripos Inc. St Louis, MO
10. Bohm HJ (1992) The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6:61-78. doi: 10.1007/BF00124387
11. Studio D (2009) Version 2.5. Accelrys Inc, San Diego
12. Wang R, Gao Y, Lai L (2000) LigBuilder: a multi-purpose program for structure-based drug design. J Mol Model 6:498-516. doi: 10.1007/s0089400060498
13. Lindahl E, Hess B, Van Der Spoel D (2001) GROMACS 3.0: a package for molecular simulation and trajectory analysis. J Mol Model 7:306-317. doi: 10.1007/s008940100045
14. Berendsen HJC, van der Spoel D, van Drunen R (1995) GROMACS: A message-passing parallel molecular dynamics implementation. Comput Phys Commun 91:43-56. doi: 10.1016/0010-4655(95)00042-E
15. Schuttelkopf AW, Van Aalten DMF (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D 60:1355-1363. doi: 10.1107/S0907444904011679
16. Berendsen HJC, Postma JPM, Van Gunsteren WF, Hermans J (1981) Interaction models for water in relation to protein hydration. Intermol Forces 331:331-342
17. Miyamoto S, Kollman PA (1992) SETTLE: an analytical version of the SHAKE and RATTLE algorithm for rigid water models. J Comput Chem 13:952-962. doi: 10.1002/jcc.540130805
18. Turner PJ (2005) XMGRACE, version 5.1. 19. Center for Coastal and Land-Margin Research, Oregon Graduate Institute of Science and Technology, Beaverton, OR
19. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33-38. doi: 10.1016/0263-7855(96)00018-5
20. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Daniel T, Repasky MP, Knoll EH, Shelley M, Perry JK (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739-1749. doi: 10.1021/jm0306430
21. Schrödinger (2009) Glide, v. 5.5. Schrödinger, New York
22. Morris G (2002) SYBYL software, version 7.1. Tripos Associates, St. Louis
23. Schrödinger Suite (2009) Protein Preparation Wizard; Epik version 2.0 S, LLC., New, York, N., 2009; Impact version 5.5, Schrödinger, LLC., New York, NY, 2009; Prime version, 2.1, S., LLC., New York, NY, 2009
24. LigPrep (2009) Schrödinger, New York
25. Schrödinger Suite (2009) Induced fit docking protocol; glide version 5.5. Schrödinger, New York
26. QikProp v. 3.2 Schrödinger, New York (2009)
27. Binda C, Li M, Hubálek F, Restelli N, Edmondson DE, Mattevi A (2003) Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures. Proc Natl Acad Sci USA 100:9750. doi: 10.1073/pnas.1633804100
28. DeLano WL (2002) The PyMOL user's manual. DeLano Scientific, San Carlos, CA
29. MOE 2007.09 Schrödinger, MO (2009)